University of Iowa Health Care and UK-based Naitive Technologies have initiated a joint project to evaluate the diagnostic accuracy of OsteoSight, an FDA-designated breakthrough medical device. This device is designed to identify individuals at risk of low bone mineral density (BMD) using X-rays taken for other medical purposes. The project aims to enhance the early detection of osteoporosis, a condition affecting millions…
Medtech company Bone Index has announced the successful close of its latest financing round and a new strategic partnership with Lynx Financial. This collaboration is set to enhance Bone Index’s distribution and service capabilities across North America and the Asia Pacific regions, allowing the company to meet the increasing demand for its bone health diagnostic solutions in these key markets. The funding,…
Bone Health Technologies (BHT), a company specialized in the development of non-pharmacological solutions to improve bone health and reduce fractures, has announced the acquisition of Wellen, a Brooklyn-based health technology company specializing in exercise-based osteoporosis care. This strategic move aims to create a comprehensive, multi-modal bone health solution. The acquisition of Wellen marks a significant step toward BHT’s vision of providing a…
Bone Health Technologies (BHT), a medtech company specializing in noninvasive and drug-free solutions for low bone density, has announced the awarding of its fifth U.S. patent for Osteoboost. Osteoboost is the first and only FDA-cleared prescription medical device designed to treat osteopenia. The newly granted patent, US 12,016,790 B2, titled “Wearable Apparatus for the Treatment or Prevention of Osteopenia and Osteoporosis,” details…
Shanghai Henlius Biotech and women’s health pharma company Organon have announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an investigational biosimilar for Prolia and Xgeva (denosumab). This biosimilar aims to provide an alternative treatment for osteoporosis in postmenopausal women at high risk for fractures and for preventing skeletal-related events in patients with bone metastases.…
Hinge Health has introduced a new movement-based support program for menopause, specifically designed for those dealing with musculoskeletal (MSK) and pelvic health conditions. This innovative service, now part of Hinge Health’s digital MSK clinic, features a dedicated team of physical therapists who provide customized exercise therapy and lifestyle modifications to help alleviate joint and muscle pain, maintain muscle mass and bone density,…
Solarea Bio, a US-based clinical-stage biotech company, is pioneering a new approach to bone health management with the beta launch of Bondia. The company is dedicated to leveraging microbial diversity to develop innovative solutions for managing inflammatory diseases. Through its consumer health brand, Journa, the company aims to improve human wellbeing with clinically tested and naturally formulated medical food products. Bondia, a…
Bone Health Technologies (BHT) has recently closed a $5 million funding round to enhance care for individuals with low bone density. This round saw contributions from Esplanade Ventures, Berkeley Catalyst Fund, and Terumo Medical, a global leader in medical technology. The funding arrives at a crucial juncture, with BHT nearing the de novo FDA clearance for its Osteoboost vibration wearable. Osteoboost, designed…
